These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 37819581)
1. Low microsatellite instability: A distinct instability type in gastric cancer? Kohlruss M; Chakraborty S; Hapfelmeier A; Jesinghaus M; Slotta-Huspenina J; Novotny A; Sisic L; Gaida MM; Ott K; Weichert W; Pfarr N; Keller G J Cancer Res Clin Oncol; 2023 Dec; 149(20):17727-17737. PubMed ID: 37819581 [TBL] [Abstract][Full Text] [Related]
2. Prognostic implication of molecular subtypes and response to neoadjuvant chemotherapy in 760 gastric carcinomas: role of Epstein-Barr virus infection and high- and low-microsatellite instability. Kohlruss M; Grosser B; Krenauer M; Slotta-Huspenina J; Jesinghaus M; Blank S; Novotny A; Reiche M; Schmidt T; Ismani L; Hapfelmeier A; Mathias D; Meyer P; Gaida MM; Bauer L; Ott K; Weichert W; Keller G J Pathol Clin Res; 2019 Oct; 5(4):227-239. PubMed ID: 31206244 [TBL] [Abstract][Full Text] [Related]
3. Microsatellite instability and sex-specific differences of survival in gastric cancer after neoadjuvant chemotherapy without and with taxane: An observational study in real world patients. Hiltner T; Kohlruss M; Herz AL; Lorenzen S; Novotny A; Hapfelmeier A; Jesinghaus M; Slotta-Huspenina J; Sisic L; Gaida MM; Weichert W; Ott K; Keller G J Cancer Res Clin Oncol; 2023 Aug; 149(10):7651-7662. PubMed ID: 37000259 [TBL] [Abstract][Full Text] [Related]
4. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer. Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687 [TBL] [Abstract][Full Text] [Related]
5. Chemosensitivity and survival in gastric cancer patients with microsatellite instability. Oki E; Kakeji Y; Zhao Y; Yoshida R; Ando K; Masuda T; Ohgaki K; Morita M; Maehara Y Ann Surg Oncol; 2009 Sep; 16(9):2510-5. PubMed ID: 19565284 [TBL] [Abstract][Full Text] [Related]
6. Tumor mutation burden is correlated with response and prognosis in microsatellite-stable (MSS) gastric cancer patients undergoing neoadjuvant chemotherapy. Li Z; Jia Y; Zhu H; Xing X; Pang F; Shan F; Li S; Wang D; Zhao F; Ma T; Wang S; Ji J Gastric Cancer; 2021 Nov; 24(6):1342-1354. PubMed ID: 34406546 [TBL] [Abstract][Full Text] [Related]
7. The benefit of microsatellite instability is attenuated by chemotherapy in stage II and stage III gastric cancer: Results from a large cohort with subgroup analyses. Kim SY; Choi YY; An JY; Shin HB; Jo A; Choi H; Seo SH; Bang HJ; Cheong JH; Hyung WJ; Noh SH Int J Cancer; 2015 Aug; 137(4):819-25. PubMed ID: 25614197 [TBL] [Abstract][Full Text] [Related]
8. Predicting the Efficacy of 5-Fluorouracil-Based Adjuvant Chemotherapy in Gastric Cancer by Microsatellite Instability: A Meta-Analysis. Zhao F; Yuan X; Ren D; Shen G; Wang Z; Zheng F; Ahmad R; Ma Z; Zhao J J Environ Pathol Toxicol Oncol; 2019; 38(1):21-28. PubMed ID: 30806287 [TBL] [Abstract][Full Text] [Related]
9. Frequent Bax frameshift mutations in gastric cancer with high but not low microsatellite instability. Yamamoto H; Itoh F; Fukushima H; Adachi Y; Itoh H; Hinoda Y; Imai K J Exp Clin Cancer Res; 1999 Mar; 18(1):103-6. PubMed ID: 10374688 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of microsatellite-instability in gastric and gastroesophageal junction cancer patients undergoing neoadjuvant chemotherapy. Haag GM; Czink E; Ahadova A; Schmidt T; Sisic L; Blank S; Heger U; Apostolidis L; Berger AK; Springfeld C; Lasitschka F; Jäger D; von Knebel Doeberitz M; Kloor M Int J Cancer; 2019 Apr; 144(7):1697-1703. PubMed ID: 30499151 [TBL] [Abstract][Full Text] [Related]
11. Microsatellite instability in sporadic gastric cancer: its prognostic role and guidance for 5-FU based chemotherapy after R0 resection. An JY; Kim H; Cheong JH; Hyung WJ; Kim H; Noh SH Int J Cancer; 2012 Jul; 131(2):505-11. PubMed ID: 21898388 [TBL] [Abstract][Full Text] [Related]
13. Immunogenic characteristics of microsatellite instability-low esophagogastric junction adenocarcinoma based on clinicopathological, molecular, immunological and survival analyses. Imamura Y; Toihata T; Haraguchi I; Ogata Y; Takamatsu M; Kuchiba A; Tanaka N; Gotoh O; Mori S; Nakashima Y; Oki E; Mori M; Oda Y; Taguchi K; Yamamoto M; Morita M; Yoshida N; Baba H; Mine S; Nunobe S; Sano T; Noda T; Watanabe M Int J Cancer; 2021 Mar; 148(5):1260-1275. PubMed ID: 32997798 [TBL] [Abstract][Full Text] [Related]
14. Microsatellite instability in solitary and sporadic gastric cancer. Perez RO; Jacob CE; D'Ottaviano FL; Alvarenga C; Ribeiro AS; Ribeiro U; Bresciani CJ; Zilberstein B; Krieger JE; Habr-Gama A; Gama-Rodrigues JJ Rev Hosp Clin Fac Med Sao Paulo; 2004 Oct; 59(5):279-85. PubMed ID: 15543400 [TBL] [Abstract][Full Text] [Related]
15. [The relationship between frameshift mutations of transforming growth factor-beta type II receptor, insulin growth factor II receptor, bcl-2 associated X protein, E2F4 and microsatellite instability in gastric carcinoma]. Chen GT; Zhu ZG; Yin HR; Liu BY; Ji J; Zhang J; Lin YZ Zhonghua Wai Ke Za Zhi; 2006 Mar; 44(5):344-8. PubMed ID: 16635398 [TBL] [Abstract][Full Text] [Related]
16. A genome-wide study of microsatellite instability in advanced gastric carcinoma. Wu CW; Chen GD; Jiang KC; Li AF; Chi CW; Lo SS; Chen JY Cancer; 2001 Jul; 92(1):92-101. PubMed ID: 11443614 [TBL] [Abstract][Full Text] [Related]
17. [Influence of neoadjuvant chemotherapy on microsatellite instability in gastric carcinoma]. Sun XW; Zhan YQ; Li W; Xu L; Li JT; Chen XJ; Zhang RH; Xu DZ Ai Zheng; 2006 Dec; 25(12):1493-6. PubMed ID: 17166373 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of telomere function in gastric cancers with and without microsatellite instability. Pascua I; Fernández-Marcelo T; Sánchez-Pernaute A; de Juan C; Head J; Torres-García AJ; Iniesta P Eur J Gastroenterol Hepatol; 2015 Feb; 27(2):162-9. PubMed ID: 25486025 [TBL] [Abstract][Full Text] [Related]
19. Elevated microsatellite instability at selected tetranucleotide (EMAST) repeats in gastric cancer: a distinct microsatellite instability type with potential clinical impact? Herz AL; Wisser S; Kohlruss M; Slotta-Huspenina J; Jesinghaus M; Grosser B; Steiger K; Novotny A; Hapfelmeier A; Schmidt T; Gaida MM; Weichert W; Keller G J Pathol Clin Res; 2022 May; 8(3):233-244. PubMed ID: 35099128 [TBL] [Abstract][Full Text] [Related]
20. Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort study. Wang J; Xiu J; Farrell A; Baca Y; Arai H; Battaglin F; Kawanishi N; Soni S; Zhang W; Millstein J; Shields AF; Grothey A; Weinberg BA; Marshall JL; Lou E; Khushman M; Sohal DPS; Hall MJ; Liu T; Oberley M; Spetzler D; Korn WM; Shen L; Lenz HJ Lancet Oncol; 2023 Feb; 24(2):151-161. PubMed ID: 36681091 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]